ArticleTherapeutic advances in medical oncology2025

Efficacy and safety of distinct regimens for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review and network meta-analysis.

Wengang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.